Split History
ETFs Holding XBI »    XBI Historical Stock Prices »
Video: What is a Stock Split?

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
SPDR S&P Biotech is an open-end investment management company. The Fund seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. As of June 30 2015, the Fund's total assets and investment porfolio totaled $3,360,344,396 and $3,327,690,681, respectively. According to our XBI split history records, SPDR Series Trust - S&P Biotech ETF has had 1 split.
XBI split history picture
SPDR Series Trust - S&P Biotech ETF (XBI) has 1 split in our XBI split history database. The split for XBI took place on September 11, 2015. This was a 3 for 1 split, meaning for each share of XBI owned pre-split, the shareholder now owned 3 shares. For example, a 1000 share position pre-split, became a 3000 share position following the split.

When a company such as SPDR Series Trust - S&P Biotech ETF splits its shares, the market capitalization before and after the split takes place remains stable, meaning the shareholder now owns more shares but each are valued at a lower price per share. Often, however, a lower priced stock on a per-share basis can attract a wider range of buyers. If that increased demand causes the share price to appreciate, then the total market capitalization rises post-split. This does not always happen, however, often depending on the underlying fundamentals of the business.

Looking at the XBI split history from start to finish, an original position size of 1000 shares would have turned into 3000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into SPDR Series Trust - S&P Biotech ETF shares, starting with a $10,000 purchase of XBI, presented on a split-history-adjusted basis factoring in the complete XBI split history. XBI split adjusted history picture

Growth of $10,000.00
With Dividends Reinvested

Start date: 02/01/2013
End date: 01/30/2023
Start price/share: $32.02
End price/share: $87.10
Starting shares: 312.30
Ending shares: 321.77
Dividends reinvested/share: $2.05
Total return: 180.26%
Average Annual Total Return: 10.86%
Starting investment: $10,000.00
Ending investment: $28,038.11
Years: 10.00
Growth of $10,000.00
Without Dividends Reinvested

Start date: 02/01/2013
End date: 01/30/2023
Start price/share: $32.02
End price/share: $87.10
Dividends collected/share: $2.05
Total return: 178.42%
Average Annual Total Return: 10.78%
Starting investment: $10,000.00
Ending investment: $27,836.43
Years: 10.00
Date Ratio
09/11/20153 for 1
XBI is categorized under the Financials sector; below are some other companies in the same sector that also have a history of stock splits:

XBKS Split History
XES Split History
XHE Split History
XHS Split History
XIN Split History
XLF Split History
XOP Split History
XPH Split History
XRT Split History
XSD Split History

Also explore: XBI shares outstanding history

Email EnvelopeFree XBI Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Liminal BioSciences Inc. (LMNL)
Galway Metals Inc. (GWM.CA)
Lannett Company, Inc. (LCI)
Reed's, Inc. (REED)
Phio Pharmaceuticals Corp. (PHIO)
Swvl Holdings Corp (SWVL)
Sientra, Inc. (SIEN)
Eargo, Inc. (EAR)
Alterity Therapeutics Limited (ATHE)
Aytu BioPharma, Inc. (AYTU)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

XBI Split History | www.SplitHistory.com | Copyright © 2013 - 2023, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.